Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase 1 2

Status

Active not recruiting 7Recruiting 3Completed 3Not yet recruiting 1Approved for marketing 1

Sponsor Class

INDUSTRY 7OTHER 2NETWORK 1

Study Type

Interventional 7

Sponsor

Cancer Type

Thoracic 7

Conditions

Carcinoma, Non-Small-Cell Lung 7

Interventions

pembrolizumab 184Carboplatin 132Cisplatin 102Paclitaxel 101Gemcitabine 86Pemetrexed 79durvalumab 75Nivolumab 67Docetaxel 55atezolizumab 51Cyclophosphamide 49Bevacizumab 49Dexamethasone 45Capecitabine 45Oxaliplatin 42130-nm albumin-bound paclitaxel 41Rituximab 40Fulvestrant 39Lenalidomide 38Fluorouracil 37Prednisone 32osimertinib 31olaparib 29venetoclax 28fludarabine 28Leucovorin 28Trastuzumab 27Doxorubicin 27Etoposide 25Cetuximab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Active not recruiting × INDUSTRY × lazertinib × Clear all
NCT04487080 2026-06-08

MARIPOSA

Janssen Research & Development, LLC

Phase 3 Active not recruiting
1,074 enrolled 13 charts 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02609776 2026-06-05

CHRYSALIS

Janssen Research & Development, LLC

Phase 1 Active not recruiting
751 enrolled 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06120140 2026-06-05

COCOON

Janssen Research & Development, LLC

Phase 2 Active not recruiting
305 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05663866 2026-06-02

Premedication to Reduce Amivantamab Associated Infusion Related Reactions

Janssen Research & Development, LLC

Phase 2 Active not recruiting
68 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04077463 2026-05-08

Chrysalis-2

Janssen Research & Development, LLC

Phase 1 Active not recruiting
701 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04988295 2026-05-08

MARIPOSA-2

Janssen Research & Development, LLC

Phase 3 Active not recruiting
776 enrolled 13 charts 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05388669 2026-05-08

PALOMA-3

Janssen Research & Development, LLC

Phase 3 Active not recruiting
418 enrolled 16 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡